These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24212595)

  • 1. [Pharmacological properties and clinical efficacy of apixaban (Eliquis(®)].
    Imai N; Fujii Y; Amano M
    Nihon Yakurigaku Zasshi; 2013 Nov; 142(5):247-54. PubMed ID: 24212595
    [No Abstract]   [Full Text] [Related]  

  • 2. Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model.
    Lester PA; Coleman DM; Diaz JA; Jackson TO; Hawley AE; Mathues AR; Grant BT; Knabb RM; Ramacciotti E; Frost CE; Song Y; Wakefield TW; Myers DD
    Arterioscler Thromb Vasc Biol; 2017 May; 37(5):942-948. PubMed ID: 28232327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apixaban (eliquis) for stroke prevention in atrial fibrillation.
    Beck RA; King WM
    Am Fam Physician; 2014 Apr; 89(8):672-5. PubMed ID: 24784127
    [No Abstract]   [Full Text] [Related]  

  • 5. New Advances in Atrial Fibrillation Management: The Role of Apixaban.
    Rosano GMC; Spoletini I; Gianni W; Vitale C
    Curr Drug Targets; 2018; 19(6):585-592. PubMed ID: 29034832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes.
    Hylek EM; Held C; Alexander JH; Lopes RD; De Caterina R; Wojdyla DM; Huber K; Jansky P; Steg PG; Hanna M; Thomas L; Wallentin L; Granger CB
    J Am Coll Cardiol; 2014 May; 63(20):2141-2147. PubMed ID: 24657685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Apixaban (Eliquis) the "ideal" anticoagulant to replace warfarin for stroke prevention in atrial fibrillation?
    Strain J; Templeton K
    S D Med; 2013 Jan; 66(1):20-1. PubMed ID: 23342716
    [No Abstract]   [Full Text] [Related]  

  • 8. Apixaban (Eliquis)--a new oral anticoagulant for atrial fibrillation.
    Med Lett Drugs Ther; 2013 Feb; 55(1409):9-10. PubMed ID: 23381226
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial.
    Held C; Hylek EM; Alexander JH; Hanna M; Lopes RD; Wojdyla DM; Thomas L; Al-Khalidi H; Alings M; Xavier D; Ansell J; Goto S; Ruzyllo W; Rosenqvist M; Verheugt FW; Zhu J; Granger CB; Wallentin L
    Eur Heart J; 2015 May; 36(20):1264-72. PubMed ID: 25499871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apixaban: a new player in the anticoagulant class.
    Agrawal R; Jain P; Dikshit SN
    Curr Drug Targets; 2012 Jun; 13(6):863-75. PubMed ID: 22250655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation and Antiplatelet Therapy in Atrial Fibrillation: A Teachable Moment.
    Edward JA; Gopal RK
    JAMA Intern Med; 2020 Sep; 180(9):1246-1247. PubMed ID: 32658260
    [No Abstract]   [Full Text] [Related]  

  • 12. Apixaban for the prevention of stroke in atrial fibrillation.
    Littrell R; Flaker G
    Expert Rev Cardiovasc Ther; 2012 Feb; 10(2):143-9. PubMed ID: 22292869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
    Lip GY; Larsen TB; Skjøth F; Rasmussen LH
    J Am Coll Cardiol; 2012 Aug; 60(8):738-46. PubMed ID: 22575324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apixaban to prevent stroke in patients with atrial fibrillation: a review.
    Peterson BE; Al-Khatib SM; Granger CB
    Ther Adv Cardiovasc Dis; 2017 Mar; 11(3):91-104. PubMed ID: 27342651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of apixaban in the patients undergoing the ablation of atrial fibrillation.
    Nagao T; Inden Y; Shimano M; Fujita M; Yanagisawa S; Kato H; Ishikawa S; Miyoshi A; Okumura S; Ohguchi S; Yamamoto T; Yoshida N; Hirai M; Murohara T
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):155-63. PubMed ID: 25487164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Not Available].
    Oldgren J
    Lakartidningen; 2018 Dec; 115():. PubMed ID: 30512140
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and Efficacy of Uninterrupted Apixaban Therapy Versus Warfarin During Atrial Fibrillation Ablation.
    Shah RR; Pillai A; Schafer P; Meggo D; McElderry T; Plumb V; Yamada T; Kumar V; Doppalapudi H; Gunter A; Pentecost E; Maddox WR
    Am J Cardiol; 2017 Aug; 120(3):404-407. PubMed ID: 28595862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Newly Diagnosed Atrial Fibrillation.
    Hernandez I; Zhang Y; Saba S
    Am J Cardiol; 2017 Nov; 120(10):1813-1819. PubMed ID: 28864318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [COMPARATIVE EFFECTIVENESS AND SAFETY OF NEW ORAL ANTICOAGULANTS AND WARFARIN IN PATIENTS WITH AGE-SPECIFIC NON-VALVULAR ATRIAL FIBRILLATION].
    Shevelev VI; Kanorsky SG
    Klin Med (Mosk); 2015; 93(7):30-6. PubMed ID: 26596056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apixaban is dear to me, but dearer still is warfarin.
    Di Biase L; Natale A
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):153-4. PubMed ID: 25625880
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.